Immunovant Inc

Stock Chart, Company Information, and Scan Results

$27.35(as of Apr 16, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Immunovant Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$27.35
Ticker SymbolIMVT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees362
CountyUSA
Market Cap$5,582.9M

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Immunovant Inc In Our Stock Scanner

As of Apr 17, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.